{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:24:04Z","timestamp":1792088644286,"version":"4.4.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["MOP-130143"],"award-info":[{"award-number":["MOP-130143"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["RMF-111623"],"award-info":[{"award-number":["RMF-111623"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"publisher","award":["2015-06397"],"award-info":[{"award-number":["2015-06397"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","award":["D2014-12"],"award-info":[{"award-number":["D2014-12"]}],"id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["105653-1"],"award-info":[{"award-number":["105653-1"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jconrel.2016.01.020","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T10:15:07Z","timestamp":1452766507000},"page":"332-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1300,"special_numbering":"C","title":["Nanoparticle\u2013liver interactions: Cellular uptake and hepatobiliary elimination"],"prefix":"10.1016","volume":"240","author":[{"given":"Yi-Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2192-3077","authenticated-orcid":false,"given":"Wilson","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"McGilvray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren C.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.01.020_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1039\/C0CS00003E","article-title":"Strategies for the intracellular delivery of nanoparticles","volume":"40","author":"Chou","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0010","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1615\/CritRevOncog.2014011563","article-title":"Nanoparticle drug formulations for cancer diagnosis and treatment","volume":"19","author":"Poon","year":"2014","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0020","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1021\/acsnano.5b01320","article-title":"Clearance pathways and tumor targeting of imaging nanoparticles","volume":"9","author":"Yu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.suc.2010.04.017","article-title":"Liver anatomy","volume":"90","author":"Abdel-Misih","year":"2010","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/SLA.0b013e31825d5d47","article-title":"Physiological and biochemical basis of clinical liver function tests","volume":"257","author":"Hoekstra","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/mp060011k","article-title":"Methods to evaluate biliary excretion of drugs in humans: an updated review","volume":"3","author":"Ghibellini","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198409010-00001","article-title":"First-pass elimination basic concepts and clinical consequences","volume":"9","author":"Pond","year":"1984","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1039\/C4TB01611D","article-title":"Diagnostic imaging and therapeutic application of nanoparticles targeting the liver","volume":"3","author":"Wang","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0050","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2011.09.098","article-title":"The journey of a drug-carrier in the body: an anatomo-physiological perspective","volume":"161","author":"Bertrand","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nantod.2010.06.007","article-title":"Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases","volume":"5","author":"Li","year":"2010","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0070","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jhep.2011.05.039","article-title":"Nanotechnology for therapy and imaging of liver diseases","volume":"55","author":"Reddy","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0075","doi-asserted-by":"crossref","first-page":"382184","DOI":"10.1155\/2013\/382184","article-title":"Efficient hepatic delivery of drugs: novel strategies and their significance","volume":"2013","author":"Mishra","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0080","series-title":"The Front Line of Host Defense","author":"Janeway","year":"2001"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0085","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0090","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0100","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0105","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/adma.200904231","article-title":"Exploring primary liver macrophages for studying quantum dot interactions with biological systems","volume":"22","author":"Fischer","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.biomaterials.2010.08.111","article-title":"Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages","volume":"32","author":"Lunov","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0120","first-page":"G605","article-title":"Mechanisms of hepatic toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin","volume":"275","author":"Thurman","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0125","series-title":"Liver Immunology. Principles and Practice","author":"Gershwin","year":"2014"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0130","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/1476-5926-2-S1-S22","article-title":"Clearance function of scavenger endothelial cells","volume":"3","author":"Smedsr\u00f8d","year":"2004","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0135","doi-asserted-by":"crossref","first-page":"11681","DOI":"10.1073\/pnas.94.21.11681","article-title":"Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells","volume":"94","author":"Kamps","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0140","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1021\/bc0501146","article-title":"A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results","volume":"16","author":"Popielarski","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0145","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0150","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0155","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.107.122481","article-title":"Cyclic Arg\u2013Gly\u2013Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats","volume":"322","author":"Du","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0160","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/smll.201402870","article-title":"The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension","volume":"11","author":"Duong","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0169-409X(89)90037-9","article-title":"Receptor-mediated delivery of drugs to hepatocytes","volume":"4","author":"Fallon","year":"1989","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(99)00364-6","article-title":"On the mechanism of hepatic transendothelial passage of large liposomes","volume":"448","author":"Romero","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0175","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/mp500394v","article-title":"Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy","volume":"12","author":"Qi","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0180","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1016\/j.biomaterials.2010.02.042","article-title":"Glycyrrhetinic acid-modified chitosan\/poly(ethylene glycol) nanoparticles for liver-targeted delivery","volume":"31","author":"Tian","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0005-2736(91)90253-5","article-title":"Specific binding of glycyrrhetinic acid to the rat liver membrane","volume":"1066","author":"Negishi","year":"1991","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2008.03.039","article-title":"Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery","volume":"359","author":"Lin","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0195","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1021\/mp900081y","article-title":"Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses","volume":"6","author":"Wu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-3659(02)00006-8","article-title":"Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers","volume":"80","author":"Opanasopit","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0205","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1016\/j.febslet.2006.05.059","article-title":"Intravenous administration of mannosylated cationic liposome\/NFkB decoy complexes effectively prevent LPS-induced cytokine production in a murine liver failure model","volume":"580","author":"Higuchi","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2014.08.048","article-title":"Ligand density at the surface of a nanoparticle and different uptake mechanism: two important factors for successful siRNA delivery to liver endothelial cells","volume":"475","author":"Akhter","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0215","first-page":"2086","article-title":"Nanocapsule-delivered sleeping beauty mediates therapeutic factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice","volume":"119","author":"Kren","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0220","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/nn302538y","article-title":"Hyaluronic acid\u2013gold nanoparticle\/interferon \u03b1 complex for targeted treatment of hepatitis C virus infection","volume":"6","author":"Lee","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10611860601141481","article-title":"Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes","volume":"15","author":"Adrian","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0230","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1211\/jpp.61.09.0004","article-title":"Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis","volume":"61","author":"Li","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/1061186X.2011.610800","article-title":"Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes","volume":"20","author":"Patel","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/jpet.106.117945","article-title":"Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats","volume":"321","author":"Adrian","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","article-title":"Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor\u2013beta on hepatic fibrosis in rats","volume":"159","author":"Li","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0250","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijpharm.2014.10.041","article-title":"Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin","volume":"478","author":"Mezghrani","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0260","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1021\/nn505166x","article-title":"Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0265","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00330-010-1988-z","article-title":"MR imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide","volume":"21","author":"Wang","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0270","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.biomaterials.2006.09.014","article-title":"Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes","volume":"28","author":"Selim","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0275","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mrm.22123","article-title":"Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo","volume":"62","author":"Lee","year":"2009","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0280","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.talanta.2006.05.064","article-title":"Identification of live liver cancer cells in a mixed cell system using galactose-conjugated fluorescent nanoparticles","volume":"71","author":"Peng","year":"2007","journal-title":"Talanta"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Xu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0290","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/mp500723k","article-title":"Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer","volume":"12","author":"Yang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0295","first-page":"140","article-title":"Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization","volume":"88","author":"Yang","year":"2008","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0300","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1039\/c3bm60099h","article-title":"Enhanced drug delivery to hepatocellular carcinoma with a galactosylated core\u2013shell polyphosphoester nanogel","volume":"1","author":"Wu","year":"2013","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0305","article-title":"Galactosylated liposomes as oligodeoxynucleotides carrier for hepatocyte-selective targeting","volume":"62","author":"Yu","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0310","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2011.03660.x","article-title":"Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury","volume":"11","author":"Jiang","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0315","doi-asserted-by":"crossref","first-page":"e44138","DOI":"10.1371\/journal.pone.0044138","article-title":"A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0320","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3109\/03639045.2012.662510","article-title":"Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir","volume":"39","author":"Gupta","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0325","doi-asserted-by":"crossref","first-page":"e47115","DOI":"10.1371\/journal.pone.0047115","article-title":"5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model","volume":"7","author":"Cheng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0330","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpharm.2012.06.039","article-title":"Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin","volume":"436","author":"Zheng","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0335","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/bc0502107","article-title":"Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells","volume":"17","author":"Liang","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0340","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.biomaterials.2005.10.027","article-title":"Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer","volume":"27","author":"Liang","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0345","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2005.07.004","article-title":"Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin","volume":"62","author":"Wang","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2010.09.012","article-title":"Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting","volume":"401","author":"Guhagarkar","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0355","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.3748\/wjg.v11.i32.4947","article-title":"Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol","volume":"11","author":"Qi","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0360","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.3390\/md11093517","article-title":"Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo","volume":"11","author":"Cheng","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0365","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.nano.2011.11.002","article-title":"Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid","volume":"8","author":"Tian","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0370","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.biomaterials.2012.06.072","article-title":"Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma","volume":"33","author":"Shi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0375","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.actbio.2010.04.021","article-title":"Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy","volume":"6","author":"Huang","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0380","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.biomaterials.2011.11.045","article-title":"Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.04.025","article-title":"Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy","volume":"451","author":"Guo","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2009.01.009","article-title":"Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system","volume":"372","author":"Cheong","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0395","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2009.07.030","article-title":"Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfate","volume":"382","author":"Longmuir","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0400","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biomaterials.2015.07.035","article-title":"CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer","volume":"67","author":"Gao","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0405","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1016\/j.biomaterials.2014.04.037","article-title":"Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0410","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2147\/IJN.S33139","article-title":"Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver","volume":"7","author":"Rui","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0415","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.biomaterials.2010.08.078","article-title":"The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis","volume":"32","author":"Skajaa","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0420","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.mt.6300168","article-title":"Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I","volume":"15","author":"Kim","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0425","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.1840090307","article-title":"Hepatic metabolism of colloidal gold-low-density lipoprotein complexes in the rat: evidence for bulk excretion of lysosomal contents into bile","volume":"9","author":"Renaud","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0430","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0435","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0440","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(99)00015-2","article-title":"Hepatic uptake of polystyrene microshperes in rats: effect of particle size on intrahepatic distribution","volume":"59","author":"Ogawara","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0450","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-409X(98)00006-4","article-title":"Extravasation of macromolecules","volume":"34","author":"Takakura","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for precision in reporting particle size parameters","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0460","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2012.02.011","article-title":"Drug targeting to the diseased liver","volume":"161","author":"Poelstra","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0465","doi-asserted-by":"crossref","DOI":"10.1023\/A:1015318415705","article-title":"Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells","volume":"19","author":"Bartsch","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0470","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1039\/C3TB21634A","article-title":"Tailored biological retention and efficient clearance of pegylated ultra-small MnO nanoparticles as positive MRI contrast agents for molecular imaging","volume":"2","author":"Chevallier","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0475","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1039\/C4TB00953C","article-title":"Biodistribution and clearance of aminoclay nanoparticles: implication for in vivo applicability as a tailor-made drug delivery carrier","volume":"2","author":"Yang","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0480","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.taap.2008.03.022","article-title":"Bio-distribution and metabolic paths of silica coated CdSeS quantum dots","volume":"230","author":"Chen","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0485","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.rli.0000197669.80475.dd","article-title":"Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent","volume":"41","author":"Bourrinet","year":"2006","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0490","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/nn901146y","article-title":"In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles","volume":"4","author":"Kumar","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0495","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/smll.201000538","article-title":"Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals","volume":"6","author":"Lu","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0500","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/adfm.201404358","article-title":"Engineering gold nanotubes with controlled length and near-infrared absorption for theranostic applications","volume":"25","author":"Ye","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0505","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/smll.200800922","article-title":"Biodistribution of 1.4- and 18-nm gold particles in rats","volume":"4","author":"Semmler-Behnke","year":"2008","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0510","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2010.12.029","article-title":"Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration","volume":"77","author":"Hirn","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0515","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00216-009-3302-y","article-title":"Characterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical forms","volume":"396","author":"Wang","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0520","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nano.2008.11.002","article-title":"Protracted elimination of gold nanoparticles from mouse liver","volume":"5","author":"Sadauskas","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0525","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.biomaterials.2009.11.079","article-title":"Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats","volume":"31","author":"Balasubramanian","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0530","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/mp7001285","article-title":"Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats","volume":"5","author":"Jain","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0535","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1038\/ncomms4796","article-title":"Nanoparticle exposure in animals can be visualized in the skin and analysed via skin biopsy","volume":"5","author":"Sykes","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0540","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1021\/nn200365a","article-title":"The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo","volume":"5","author":"Huang","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0545","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.toxlet.2009.04.017","article-title":"The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles","volume":"189","author":"Cho","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0550","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1016\/j.biomaterials.2010.03.048","article-title":"Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles","volume":"31","author":"Souris","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0555","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.biomaterials.2012.12.043","article-title":"The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes","volume":"34","author":"Fu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0560","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2012.05.046","article-title":"In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics","volume":"163","author":"Yu","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0565","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.nano.2014.05.001","article-title":"MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation","volume":"10","author":"Bulte","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0570","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1016\/j.biomaterials.2010.05.009","article-title":"Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection","volume":"31","author":"Lipka","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0575","doi-asserted-by":"crossref","DOI":"10.1038\/srep03424","article-title":"Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging","volume":"3","author":"Xiao","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0580","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12272-011-0118-z","article-title":"Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats","volume":"34","author":"Park","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0585","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.2147\/IJN.S82807","article-title":"Effects of zinc oxide nanoparticles on Kupffer cell phagosomal motility, bacterial clearance, and liver function","volume":"10","author":"Watson","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0590","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1021\/nn4030898","article-title":"Magnetic\/upconversion fluorescent NaGdF4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo","volume":"7","author":"Liu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0595","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/wnan.1157","article-title":"Recent advances in stealth coating of nanoparticle drug delivery systems","volume":"4","author":"Amoozgar","year":"2012","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0600","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/17425247.2011.554818","article-title":"Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems","volume":"8","author":"Karmali","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0605","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0610","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0615","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0620","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.jmmm.2003.12.852","article-title":"Long-term retention of dextran-coated magnetite nanoparticles in the liver and spleen","volume":"272\u2013276","author":"Lacava","year":"2004","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0625","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1021\/acsnano.5b00042","article-title":"The one year fate of iron oxide coated gold nanoparticles in mice","volume":"9","author":"Kolosnjaj-Tabi","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0630","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/smll.200700378","article-title":"Size-dependent cytotoxicity of gold nanoparticles","volume":"3","author":"Pan","year":"2007","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0635","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1021\/nn800511k","article-title":"Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties","volume":"2","author":"Xia","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0640","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/nn901503q","article-title":"Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping","volume":"4","author":"George","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0645","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1039\/c3nr02140h","article-title":"Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo","volume":"5","author":"Paek","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0650","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1012942409274","article-title":"Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology","volume":"14","author":"Krebs","year":"2001","journal-title":"Biometals"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0655","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1039\/c2mt00185c","article-title":"Cellular transport and homeostasis of essential and nonessential metals","volume":"4","author":"Martinez-Finley","year":"2012","journal-title":"Metallomics"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0660","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1039\/b816714c","article-title":"A general map of iron metabolism and tissue-specific subnetworks","volume":"5","author":"Hower","year":"2009","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0665","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.taap.2004.06.021","article-title":"Iron metabolism and toxicity","volume":"202","author":"Papanikolaou","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0670","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00441-004-0884-8","article-title":"Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging","volume":"316","author":"Briley-Saebo","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0675","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1016\/j.biomaterials.2011.02.031","article-title":"Long term in vivo biotransformation of iron oxide nanoparticles","volume":"32","author":"Levy","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0680","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1042\/bj0320426","article-title":"The biochemistry of silicic acid","volume":"32","author":"King","year":"1938","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0685","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/smll.200900923","article-title":"Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles","volume":"5","author":"He","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0690","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmat2398","article-title":"Biodegradable luminescent porous silicon nanoparticles for in vivo applications","volume":"8","author":"Park","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0695","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.1021\/ac801882g","article-title":"In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles","volume":"80","author":"He","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0700","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1021\/acsnano.5b00526","article-title":"In vivo integrity and biological fate of chelator-free zirconium-89-labeled mesoporous silica nanoparticles","volume":"9","author":"Chen","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0705","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting \u2014 strategies and applications","volume":"203","author":"D'Souza","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0710","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/mabi.200600075","article-title":"Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery","volume":"6","author":"Bergen","year":"2006","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0715","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nbt843","article-title":"Nanoparticles for the delivery of genes and drugs to human hepatocytes","volume":"21","author":"Yamada","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0720","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1021\/nn300558p","article-title":"Visualizing dynamics of sub-hepatic distribution of nanoparticles using intravital multiphoton fluorescence microscopy","volume":"6","author":"Cheng","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0725","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0021-9258(19)69746-2","article-title":"Rapid oxidation in vitro of endogenous and exogenous glutathione in bile of rats","volume":"256","author":"Eberle","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0730","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/mrm.20513","article-title":"Quantification of glycine and taurine conjugated bile acids in human bile using 1H NMR spectroscopy","volume":"53","author":"Ijare","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0735","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1039\/C4TB01954G","article-title":"Validation of a dendron concept to tune colloidal stability, MRI relaxivity and bioelimination of functional nanoparticles","volume":"3","author":"Walter","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0740","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.biomaterials.2011.07.026","article-title":"Dendronized iron oxide nanoparticles for multimodal imaging","volume":"32","author":"Lamanna","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0745","doi-asserted-by":"crossref","first-page":"16020","DOI":"10.1117\/1.JBO.20.1.016020","article-title":"Visualizing and quantifying difference in cytoplasmic and nuclear metabolism in the hepatobiliary system in vivo","volume":"20","author":"Lin","year":"2015","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0750","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0755","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2011.04.023","article-title":"Novel geometry type of nanocarriers mitigated the phagocytosis for drug delivery","volume":"154","author":"Lin","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0760","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejpb.2010.11.010","article-title":"Ghandehari, geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages","volume":"77","author":"Arnida","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0765","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","article-title":"Size and shape effects in the biodistribution of intravascularly injected particles","volume":"141","author":"Decuzzi","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0770","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","article-title":"Shape induced inhibition of phagocytosis of polymer particles","volume":"26","author":"Champion","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0775","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.actbio.2011.07.033","article-title":"Criteria impacting the cellular uptake of nanoparticles: a study emphasizing polymer type and surfactant effects","volume":"7","author":"Musyanovych","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0780","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1242\/jcs.115.4.849","article-title":"Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target","volume":"115","author":"Beningo","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0785","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1073\/pnas.1010013108","article-title":"Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles","volume":"108","author":"Merkel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0790","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0169-409X(95)00030-B","article-title":"Liposome circulation time and tumor targeting: implications for cancer chemotherapy","volume":"16","author":"Gabizon","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0795","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1002\/anie.201309464","article-title":"Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting","volume":"53","author":"Dai","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0800","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1021\/nn100262h","article-title":"Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry","volume":"4","author":"Bartneck","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0805","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nchem.1213","article-title":"Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity","volume":"4","author":"Keefe","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0810","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1021\/la500057j","article-title":"Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption","volume":"30","author":"Schlenoff","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0815","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/adma.200901407","article-title":"Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications","volume":"22","author":"Jiang","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0820","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nantod.2014.12.003","article-title":"RES blockade: a strategy for boosting efficiency of nanoparticle drug","volume":"10","author":"Liu","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0825","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0830","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposome mediated depletion of macrophage, mechanism of action, preparation of liposomes and applications","volume":"174","author":"van Rooijen","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0835","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10611860802228426","article-title":"Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages","volume":"16","author":"van Rooijen","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0840","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/mol.61.5.1255","article-title":"Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"62","author":"Lehenkari","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0845","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2353\/ajpath.2009.090258","article-title":"SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophages","volume":"175","author":"Kirby","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0850","first-page":"681","article-title":"Effect of macrophage elimination using liposome-encapsulated dichloromethylene diphosphonate on tissue distribution of liposomes","volume":"6","author":"Hu","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0855","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/ijc.27502","article-title":"Effective delivery of chemotherapeutic nanoparticles by depleting host Kupffer cells","volume":"131","author":"Ohara","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0860","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1073\/pnas.0610298104","article-title":"Biomimetic amplification of nanoparticle homing to tumors","volume":"104","author":"Simberg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0865","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.nucmedbio.2008.02.001","article-title":"The fate of MAb-targeted Cd125mTe\/ZnS nanoparticles in vivo","volume":"35","author":"Kennel","year":"2008","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0870","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0168-8278(96)80302-3","article-title":"In vivo assessment of hepatic alterations following gadolinium chloride-induced Kupffer cell blockade","volume":"25","author":"Ruttinger","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0875","first-page":"624","article-title":"Electron microscopic study of Kupffer-cell phagocytosis blockade induced by gadolinium chloride","volume":"61","author":"Husztik","year":"1980","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0880","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jlb.52.3.296","article-title":"Heterogeneity of rat liver and spleen macrophages in Gadolinium chloride-induced elimination and repopulation","volume":"52","author":"Hardonk","year":"1992","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0885","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1021\/nn901919w","article-title":"Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivo","volume":"4","author":"Diagaradjane","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0890","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0895","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0900","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0905","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1021\/nl072209h","article-title":"A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors","volume":"7","author":"Choi","year":"2007","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0910","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2012.02.022","article-title":"Use of macrophages to deliver therapeutic and imaging contrast agents to tumors","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.01.020_bb0915","doi-asserted-by":"crossref","first-page":"21495","DOI":"10.1073\/pnas.0907127106","article-title":"Red blood cell-mimicking synthetic biomaterial particles","volume":"106","author":"Doshi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.01.020_bb0920","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nnano.2013.54","article-title":"A biomimetic nanosponge that absorbs pore-forming toxins","volume":"8","author":"Hu","year":"2013","journal-title":"Nat. Nanotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916300190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916300190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:45Z","timestamp":1748736045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916300190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":184,"alternative-id":["S0168365916300190"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle\u2013liver interactions: Cellular uptake and hepatobiliary elimination","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}